OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Exelixis Inc/  US30161Q1040  /

NASDAQ
2024-05-13  10:00:00 PM Chg. -0.1000 Volume Bid10:00:07 AM Ask10:00:07 AM High Low
21.2700USD -0.47% 1.99 mill.
Turnover: 26.62 mill.		 19.5000Bid Size: 100 22.0000Ask Size: 100 21.5900 21.1250
GlobeNewswire 05-09 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 05-01 Giants of Cancer Care® Announces the 12th Annual Class of Inductees
GlobeNewswire 03-29 Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-04 Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer
GlobeNewswire 02-15 Royalty Pharma Reports Q4 and Full Year 2023 Results
GlobeNewswire 02-14 Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focu...
GlobeNewswire 02-06 Cybrexa Regains Rights to CBX-12
GlobeNewswire 01-08 XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of t...
GlobeNewswire 01-04 Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
GlobeNewswire 2023-12-26 Harpoon Therapeutics Strengthens Leadership Team
GlobeNewswire 2023-12-11 Ryvu Therapeutics Presents Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Me...
GlobeNewswire 2023-12-07 Ryvu Therapeutics Presents Data on RVU120 at the San Antonio Breast Cancer Symposium 2023
GlobeNewswire 2023-11-29 Ryvu Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire 2023-11-15 Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
GlobeNewswire 2023-11-08 Royalty Pharma Reports Third Quarter 2023 Results
GlobeNewswire 2023-11-01 Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
GlobeNewswire 2023-10-23 Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Soli...
GlobeNewswire 2023-10-17 Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors
GlobeNewswire 2023-10-04 Ryvu Therapeutics to Present Preclinical Data on PRMT5 and its Synthetic Lethality Platform at the 2...
GlobeNewswire 2023-09-13 Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update
GlobeNewswire 2023-08-31 Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
GlobeNewswire 2023-08-21 Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Caboza...
GlobeNewswire 2022-02-15 Royalty Pharma Reports Q4 and Full Year 2021 Results
GlobeNewswire 2022-01-18 Fountain Therapeutics Announces Appointment of Anupama Hoey as Chief Business Officer
GlobeNewswire 2021-12-22 Adagene Achieves Key Milestone in Collaboration with Exelixis for SAFEbody® Novel Masked Antibody-Dr...